Annual Working Capital
$85.31 M
-$55.09 M-39.24%
December 31, 2023
Summary
- As of February 26, 2025, RLMD annual working capital is $85.31 million, with the most recent change of -$55.09 million (-39.24%) on December 31, 2023.
- During the last 3 years, RLMD annual working capital has fallen by -$20.16 million (-19.11%).
- RLMD annual working capital is now -59.03% below its all-time high of $208.24 million, reached on December 31, 2021.
Performance
RLMD Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$47.62 M
-$13.82 M-22.50%
September 30, 2024
Summary
- As of February 26, 2025, RLMD quarterly working capital is $47.62 million, with the most recent change of -$13.82 million (-22.50%) on September 30, 2024.
- Over the past year, RLMD quarterly working capital has dropped by -$24.39 million (-33.87%).
- RLMD quarterly working capital is now -77.37% below its all-time high of $210.37 million, reached on March 31, 2022.
Performance
RLMD Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
RLMD Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.2% | -33.9% |
| 3 y3 years | -19.1% | -34.5% |
| 5 y5 years | +1056.3% | +726.5% |
RLMD Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -59.0% | at low | -77.4% | at low |
| 5 y | 5-year | -59.0% | at low | -77.4% | +726.5% |
| alltime | all time | -59.0% | +2794.1% | -77.4% | +330.6% |
Relmada Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $47.62 M(-22.5%) |
| Jun 2024 | - | $61.44 M(-14.7%) |
| Mar 2024 | - | $72.00 M(-15.6%) |
| Dec 2023 | $85.31 M(-39.2%) | $85.31 M(-15.3%) |
| Sep 2023 | - | $100.68 M(-9.5%) |
| Jun 2023 | - | $111.30 M(-11.3%) |
| Mar 2023 | - | $125.43 M(-10.7%) |
| Dec 2022 | $140.40 M(-32.6%) | $140.40 M(-15.6%) |
| Sep 2022 | - | $166.33 M(-15.5%) |
| Jun 2022 | - | $196.82 M(-6.4%) |
| Mar 2022 | - | $210.37 M(+1.0%) |
| Dec 2021 | $208.24 M(+97.4%) | $208.24 M(+186.7%) |
| Sep 2021 | - | $72.64 M(-24.9%) |
| Jun 2021 | - | $96.78 M(+6.3%) |
| Mar 2021 | - | $91.06 M(-13.7%) |
| Dec 2020 | $105.47 M(-8.7%) | $105.47 M(-13.6%) |
| Sep 2020 | - | $122.08 M(-7.6%) |
| Jun 2020 | - | $132.08 M(+16.9%) |
| Mar 2020 | - | $112.98 M(+1861.0%) |
| Dec 2019 | $115.48 M(+1465.2%) | - |
| Sep 2019 | - | $5.76 M(-21.9%) |
| Jun 2019 | $7.38 M | $7.38 M(+3579.8%) |
| Mar 2019 | - | $200.50 K(-82.8%) |
| Dec 2018 | - | $1.17 M(-120.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -$5.83 M(+84.2%) |
| Jun 2018 | -$3.17 M(-388.3%) | -$3.17 M(+200.3%) |
| Mar 2018 | - | -$1.05 M(-163.3%) |
| Dec 2017 | - | $1.67 M(-7.1%) |
| Sep 2017 | - | $1.80 M(+63.4%) |
| Jun 2017 | $1.10 M(-82.4%) | $1.10 M(-45.5%) |
| Mar 2017 | - | $2.01 M(-48.1%) |
| Dec 2016 | - | $3.88 M(-18.4%) |
| Sep 2016 | - | $4.76 M(-23.7%) |
| Jun 2016 | $6.24 M(-25.6%) | $6.24 M(-33.4%) |
| Mar 2016 | - | $9.37 M(-13.8%) |
| Dec 2015 | - | $10.87 M(-18.9%) |
| Sep 2015 | - | $13.40 M(+59.8%) |
| Jun 2015 | $8.39 M(-913.4%) | $8.39 M(+227.7%) |
| Mar 2015 | - | $2.56 M(-45.1%) |
| Dec 2014 | - | $4.66 M(-122.6%) |
| Sep 2014 | - | -$20.65 M(>+9900.0%) |
| Jun 2014 | -$1.03 M(+6682.2%) | - |
| Feb 2014 | - | -$32.40 K(+10.2%) |
| Nov 2013 | - | -$29.40 K(+93.4%) |
| Aug 2013 | -$15.20 K(-233.3%) | -$15.20 K(-33.9%) |
| May 2013 | - | -$23.00 K(+1177.8%) |
| Feb 2013 | - | -$1800.00(-115.8%) |
| Aug 2012 | $11.40 K | $11.40 K |
FAQ
- What is Relmada Therapeutics annual working capital?
- What is the all time high annual working capital for Relmada Therapeutics?
- What is Relmada Therapeutics annual working capital year-on-year change?
- What is Relmada Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Relmada Therapeutics?
- What is Relmada Therapeutics quarterly working capital year-on-year change?
What is Relmada Therapeutics annual working capital?
The current annual working capital of RLMD is $85.31 M
What is the all time high annual working capital for Relmada Therapeutics?
Relmada Therapeutics all-time high annual working capital is $208.24 M
What is Relmada Therapeutics annual working capital year-on-year change?
Over the past year, RLMD annual working capital has changed by -$55.09 M (-39.24%)
What is Relmada Therapeutics quarterly working capital?
The current quarterly working capital of RLMD is $47.62 M
What is the all time high quarterly working capital for Relmada Therapeutics?
Relmada Therapeutics all-time high quarterly working capital is $210.37 M
What is Relmada Therapeutics quarterly working capital year-on-year change?
Over the past year, RLMD quarterly working capital has changed by -$24.39 M (-33.87%)